News
🇺🇸 FDA Page 46Latest pharmaceutical news, drug approvals, and FDA regulatory updates
Showing 541–552 of 807 articles
Fierce Biotech Week 2026: What to Expect in Boston
BioMed Israel 2026: AI & Biotech Innovations Recap
OCT East Coast 2026: CRO Trends & Outsourcing Strategies
INTERPHEX 2026 Biotech Day 1: Key Takeaways
Alterity Therapeutics ATH434 Shows Reduced Functional Decline in Multiple System Atrophy Phase 2 Trial
Tempest Therapeutics Achieves Manufacturing Milestone for TPST-2003 CAR-T Cancer Treatment
Phanes Therapeutics to Present Updated Spevatamig Phase 2 Results for Metastatic Pancreatic Cancer at ASCO 2026
NETRIS Pharma's NP137 Shows Promising Results in Pancreatic Cancer Phase 1b Trial Published in Nature
Neurosterix NTX-253 Phase 1 Schizophrenia Trial On Track for Q2 2026 Completion
Mabwell 9MW2821 Combination Therapy Data to Be Presented at ASCO 2026 for Urothelial Carcinoma Treatment
FDA Issues Complete Response Letter for Atara Biotherapeutics' EBVALLO Cancer Treatment, Triggering Securities Lawsuit
ImmunityBio (IBRX) Faces Securities Lawsuit After FDA Warning Letter Over Cancer Treatment Claims